Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Director dealings: Tristel non-exec buys first shares, LSE buyback continues

(Sharecast News) - On the list of director buys on Monday was Tristel, after a non-executive director spent almost £30k on shares. The infection prevention products manufacturer said that on 23 June, Tom Jenkins purchased 8,000 of its shares in a single transaction on the London Stock Exchange.

Jenkins paid 372p for each share, valuing the investment at a total of £29,760.

In its disclosure, Tristel said Jenkins' beneficial interest in the company now stood at 8,000 of its shares, representing 0.02% of its total issued share capital.

London Stock Exchange Group was once again representing the selling side of the ledger, as the buyback programme launched in the wake of its acquisition of Refinitiv rolled on.

The company said York Holdings II sold back another 12,071 of its shares, in a single transaction that also took place on 23 June.

It received 8,401.94p for each share, valuing the transaction at £1,014,198.18.

The exchange operator said in its disclosure that one of its directors, Martin Brand, is also a director of York Holdings II.

It is understood that York Holdings II is part of the structure of entities that holds the LSE Group shares that formed part of the consideration paid to Thomson Reuters and Blackstone on completion of its acquisition of Refinitiv.

A number of those shares exited lock-in restrictions earlier this year, leading to a share buyback agreement between LSE Group and the vendors of Refinitiv.

At 1439 BST, shares in London Stock Exchange Group were down 0.07% at 8,416p, while those in Tristel were 3.99% weaker at 364.84p.

Reporting by Josh White for Sharecast.com.

Top Director Buys

Oakley Capital Investments Ltd. (di) (OCI) Director name: Till,David Amount purchased: 50,000 @ 4,460.00p Value: �2,229,999.92

Oakley Capital Investments Ltd. (di) (OCI) Director name: Dubens,Peter Amount purchased: 200,000 @ 446.00p Value: �892,000.01

Lookers (LOOK) Director name: Raban,Mark Douglas Amount purchased: 93,709 @ 118.60p Value: �111,138.87

Lookers (LOOK) Director name: Laird,Oliver Amount purchased: 58,307 @ 118.60p Value: �69,152.10

Lookers (LOOK) Director name: McPhee,Duncan Amount purchased: 58,307 @ 118.60p Value: �69,152.10

Tullow Oil (TLW) Director name: Goethe,Roald Amount purchased: 150,000 @ 29.69p Value: �44,527.50

Tullow Oil (TLW) Director name: Goethe,Roald Amount purchased: 150,000 @ 29.48p Value: �44,221.50

Tullow Oil (TLW) Director name: Goethe,Roald Amount purchased: 150,000 @ 28.98p Value: �43,471.50

Tristel (TSTL) Director name: Jenkins,Tom Amount purchased: 8,000 @ 372.00p Value: �29,760.00

Centralnic Group (CNIC) Director name: Royde ,Max Amount purchased: 18,000 @ 111.09p Value: �19,996.02

European Assets Trust (EAT) Director name: Troup,Kevin Amount purchased: 20,000 @ 86.60p Value: �17,319.40

Roquefort Therapeutics (ROQ) Director name: West,Stephen Paul Amount purchased: 144,117 @ 6.90p Value: �9,944.07

European Assets Trust (EAT) Director name: Breuer,Martin Amount purchased: 6,700 @ 87.00p Value: �5,829.00

Roquefort Therapeutics (ROQ) Director name: Reginald,Trevor Ajanthan (Ajan) Amount purchased: 35,265 @ 7.06p Value: �2,489.71

Top Director Sells

London Stock Exchange Group (LSEG) Director name: Brand,Martin Amount sold: 12,071 @ 8,401.97p Value: �1,014,201.79

Share this article

Related Sharecast Articles

Director dealings: Blue Coast raises stake in Everyman Media
(Sharecast News) - Everyman Media revealed on Thursday that Blue Coast had acquired 50,000 ordinary shares in the AIM-listed cinema group.
Director dealings: Angus Energy CEO ups stake
(Sharecast News) - Angus Energy revealed on Wednesday that chief executive Richard Herbert had acquired 5.0m ordinary shares in the AIM-listed onshore oil and gas development firm.
Director dealings: Abrdn CEO makes share sale
(Sharecast News) - Abrdn revealed on Monday that chief executive Stephen Bird had disposed of 29,942 ordinary shares in the FTSE 250-listed global investment company.
Director dealings: Redx Pharma CEO ups stake
(Sharecast News) - Redx Pharma revealed on Friday that chief executive Lisa Anson had acquired 399,000 ordinary shares in the AIM-listed clinical-stage biopharmaceutical firm.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.